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The chemical diversity of nature has tremendous
potential for the discovery of molecular probes and
medicinal agents. However, sensitivity of HTS assays
to interfering components of crude extracts derived
from plants, and macro- and microorganisms has
curtailed their use in lead discovery. Here, we de-
scribe a process for leveraging the concentration-
response curves obtained from quantitative HTS to
improve the initial selection of ‘‘actives’’ froma library
of partially fractionated natural product extracts
derived from marine actinomycetes and fungi. By
using pharmacological activity, the first-pass CRC
paradigm improves the probability that labor-inten-
sive subsequent steps of reculturing, extraction,
and bioassay-guided isolation of active compo-
nent(s) target the most promising strains and growth
conditions. We illustrate how this process identified
a family of fungal metabolites as potent inhibitors of
firefly luciferase, subsequently resolved in molecular
detail by X-ray crystallography.
INTRODUCTION
Natural products (NPs) are unparalleled in representation among
both drugs and chemical probes, and as many as 63% of the
new chemical entities for drugs discovered between 1981 and
2006 have been traced to or based on these structurally diverse
secondary metabolites (Carlson, 2010; Newman, 2008; Newman1442 Chemistry & Biology 18, 1442–1452, November 23, 2011 ª2011and Cragg, 2009). Recent studies have revealed that 34
NP-based drugs have been approved between 1998 and 2007
(Butler, 2008). However, naturally-derived small molecules have
received less attention in recent years, due in part to the laborious
process involved in identification, isolation, and follow-up
compared to leads derived from synthetic libraries (Li and Vede-
ras, 2009). Screening of NP libraries often included a time-
demanding workflow of deconvolution, and validation that
became unsustainable when compared to the timelines achiev-
able from HTS of synthetic chemical libraries. Paradoxically,
despite the prevalence of NPs among successful drugs and
powerful chemical probes, this burden resulted in the curtailing
or termination of NP extract (NPE)-based discovery efforts at
many pharmaceutical companies over the last decade (Harvey,
2007; Koehn and Carter, 2005; Lam, 2007; Newman, 2008).
To sample maximum chemical diversity in NPE-based
screening, the library should remain sufficiently rich in chemical
matter but devoid of undesirable characteristics that make it
difficult to test with highly sensitive HTS assays (Harvey, 2007;
Inglese et al., 2007; Koehn and Carter, 2005). For this reason
we focused on NPE libraries where partial or prefractionation
of the crude extracts was accomplished and accompanied
by elution profile data. Fractionated extracts help reduce or
eliminate artifacts associated with crude material. For example,
crude organic solvent extracts are relatively straightforward
to prepare, but the high concentrations of salts, pigments,
and polymeric constituents can interfere significantly with sensi-
tive detection outputs of modern HTS. Compound-mediated
phenomena complicating the interpretation of HTS data are
becoming increasingly well characterized (Baell and Holloway,
2010; Inglese et al., 2007; Thorne et al., 2010a).
To improve efficiency of NP identification, we explored a new
strategy that integrates recent advances in HTS and NPE libraryElsevier Ltd All rights reserved
Figure 1. Activity Analysis of NPEs in Various Assays
(A) Bar chart summarizing active NPEs in assays ordered by format: 1–15 are fluorogenic; 16–18 are fluorescent polarization; 19–30 are bioluminescent; 31–32
ALPHA-based chemiluminescent; 33–34 use fluorescent protein expression; and 35 is an absorbance output. The number of active NPEs per assay is indicated
on the y axis, where red represents a class 1a CRC (as previously defined [Inglese et al., 2006]), whereas 3 SD and 6 SD cutoffs for activity at a single apparent
concentration of 10 mM are given by the gray and black bars. One class 1a CRC falls in assay 29, see Table S1.
(B) Plots showing qHTS class 1a CRC results from assays selected for further analysis (see also Figure S2B). Assays 19, 20, and 26 displayed activity from
a common strain, NPE 05545.
Additional assay details can be found in Table S1.
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qHTS Evaluation of Natural Product Extractsproduction to enable a more efficient means of isolating active
components from NP sources. Specifically, we chose ‘‘prefrac-
tionated’’ NPEs from culturable microorganisms that are
prepared by differential solvent extraction of initially XAD resin-
bound NPEs into three ‘‘prefractions’’ that are transferred to
a 384-well plate (see Figure S1A available online). We also em-
ployed a titration-based screening paradigm, quantitative HTS
(qHTS) (Inglese et al., 2006), where samples in large chemical
libraries can be rapidly tested at different concentrations, and
concentration-response curves (CRCs) are fitted to the data.
Titration of the different solvent extractions provides a further
dimension of resolution where pharmacological activity of the
CRCs is correlated with the NPE elution profile data. Further-
more, in such an approach samples can be formatted into
a 1536-well-based titration archive suitable for rapid screening
(Figure S1B) (Yasgar et al., 2008). The use of a CRC classification
scheme (Inglese et al., 2006; Shukla et al., 2009), derived from
qHTS to select active wells, provides a unique means to track
active components in association with the sample elution profile,
and provides higher confidence data to ensure that typical HTS
artifacts are largely avoided. A successful major effort using our
screening paradigm could reinitiate and improve the application
of this fertile area of NP chemical probe and drug discovery.
Here, we report our methodology and initial validation involving
qHTS in the testing of NPE libraries derived from Costa Rica
marine microbial resources.
RESULTS
Evaluation of an NPE Library by qHTS
In an effort to improve the process of identifying biological
activity from NPE libraries, we tested extracts in qHTS format
across 35 diverse assays that were optimized for 1536-well
format (Table S1). To reduce the ionic, optical, and aggrega-Chemistry & Biology 18, 1442–145tion-based interference from high-salt concentration, pigments,
polymeric organics, and other resinous materials, we prepared
the extracts using XAD resin to enrich the NPs from these genet-
ically diverse and pure culture actinomycete and fungal strains
while reducing the content of biomass at the extremes of polarity
(e.g., nonorganic or highly lipophilic).
The NPE library we subsequently prepared for qHTS con-
tained 15,704 samples that comprised 13 separate 7-concentra-
tion inter-plate titration series, such that overall, 91 individual
1536-well plates were maintained as a titration archive for
screening (Figure S1B). As a dynamic library that increases in
size over time, a subset of the archived library (5300 samples)
was tested in the diverse assay panel to estimate the relative
activity of the extracts. By examining data from a single-tested
concentration, qHTS data can also be examined as a traditional
single-point high-throughput screen. A retrospective analysis of
the activity from the preliminary testing of the NPE library across
the assays in this manner resulted in a broad range of activity
from none to several thousand actives (Figure 1A) at either 3 or
6 standard deviations (SDs) as a cutoff for biological activity.
From this subset, ‘‘hit’’ rates spanning 0%–80% for 3SD or an
average of 11%, and 0%–50% for 6 SD or average of 4.5%
were observed. The highest hit rates, those above 5% (3 SD),
were all limited to biochemical assays except for one that
measured cellular viability (assay 26, Figure 1A). Using qHTS
analysis among the assays tested, 10 gave high-quality class
1a CRCs (Figures 1A and 1B). These assays were comprised
of 2 cell-based assays and 8 biochemical assays that employed
detection formats of fluorescence, absorbance, and biolumines-
cence, with 5 of the 10 based on firefly luciferase (FLuc) outputs.
Initially, we decided to follow up actives from screens employing
purified molecular targets, based primarily on a high-quality
pharmacological response in a single assay. A particular extract
(Papua New Guinea 05441) with high apparent potency 1a2, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1443
Figure 2. Bioactivity-Guided Dereplication of NPE 05545
(A) Thin-layer chromatography analysis of flash-column fractions from an acetone extract of XAD-16-bound culture extract from strain 05545.
(B) Activity of flash-column fractions shown in (A) in FLuc enzyme assay (open square, X+A; solid triangle, 7a; open triangle, 7b, closed square, 7c; solid circle, 7d;
open circle, 7e).
(C) Thin-layer chromatography analysis of flash-column fractions from an independent culture of 05545.
(D) Reverse HPLC of the components of flash column fraction 6c in (C).
(E) Activity from the HPLC separation shown in (C).
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Kinase IIa (assay #25; Figures 1A and 1B); however, a retest with
a new extract from the same strain did not yield the original
activity (Figure S2A), illustrating the challenges of working with
uncharacterized mixtures and the importance of initial selection
criteria limiting the number of follow-ups. However, several
assays (#19, #20, #26) based on a common FLuc output showed
CRCs from a number of NPEs, suggesting to us that these NPEs
potentially contained FLuc inhibitors (Figure 1; Figure S2B).
However, more restricted in prevalence were class 1a CRCs
(e.g., Costa Rica strain 05545 and 06085). Using this observation
to strengthen the commitment to proceed with dereplication, we
recultured strain 05545 and initiated the isolation of the active
constituents of this NPE (Figure 2).
Structural Characterization of a Series of Aspulvinones
The strain 05545, a marine fungus from the genus Aspergillus
(determined by 18S rRNA gene sequence analysis; data not
shown), was isolated from Costa Rica marine sediments,
collected in Isla Despensa, Guanacaste Conservation Area in
December 2005. The terrestrial Aspergillus sp. is known by the
production of pulvinone derivatives, unsaturated tetronic acids
with an aryl substituent at C2, an arylmethylene substituent at
C4, and isoprene residues in the aryl rings (Ojima et al., 1975).
The marine fungus was scaled-up to 5 l, and the active
extracts were subjected to chromatographic separation using1444 Chemistry & Biology 18, 1442–1452, November 23, 2011 ª2011a combination of MPLC and HPLC (Figure 2). The fractionation
of active extracts was followed by secondary bioassay to guide
isolation of six newderivatives, aspulvinones I-CR toM-CR (4–9),
in addition to known aspulvinones E, F, and H (1–3) (Sugiyama
et al., 1979; Ojima et al., 1975), as well as butyrolactone I and
III (10 and 11) (Rao et al., 2000; Parvatkar et al., 2009; Niu
et al., 2008) and benzofuran (12) (Donnelly et al., 1988; Huang
et al., 2008) (Figure 3). Aspulvinone F (2) was reported in 1975
with an incorrect structure (Ojima et al., 1975), and in 1979 it
was reconsidered by Begley et al. (1979), who suggested that
aspulvinone F likely bears a dihydrofuran ring instead of an
epoxide. Our NMR data and X-ray crystallographic analysis
reveal that the proposed revised structure is formally confirmed,
and the absolute configuration of the chiral center was estab-
lished as R (Figures 4A and 4B).
Aspulvinone I-CR (4) was isolated as a pale-yellow solid.
The HREIMS gave an [M] ion at m/z 479.1659, consistent
with the molecular formula C27H28O8, requiring 14 sites of
unsaturation and 16 amu more than compound 2 (C27H28O7).
The 1H-NMR and 13C-NMR data indicated that the structure of
4 is very similar to compound 2. The most significant differences
in the NMR data reside in the high-field shift effect of the signal
at C-23 (dH 3.19, dC 31.8) and the presence of a sp
3 methine
instead of a sp3 methylene at C-24, (dH 4.61, dC 91.4). These
data indicated that compound 4 bears a dihydrofuran ring fused
to the benzene ring, as opposed to the dihydropyran ring presentElsevier Ltd All rights reserved
Figure 3. Structures of Isolated Metabolites
Aspulvinone E (1), aspulvinone F (2), aspulvinoneH (3), aspulvinone I-CR (4), aspulvinone J-CR (5), aspulvinone K-CR (6), aspulvinone L-CR (7), aspulvinoneM-CR
(8), aspulvinone N-CR (9), butyrolactone I (10), butyrolactone III (11), and benzofuran (12). 1H- and 13C-NMR, COSY, and HSQC spectra for compounds 2 and 4–9
are provided in Figures S4–S31 and Tables S3 and S4.
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HSQC, and HMBC spectra. COSY correlations between H2-23
and H-24, as well as between H2-18 and H-19, supported the
presence of two dihydrofuran ring systems. HMBC correlation
from H2-18 to C-9 and C-10, H-8 to C-10, H-7, and H-11 to C-
9, H2-23 to C-15 andC-17, andH-17 to C-23 confirmed the pres-
ence of a dihydrofuran fused to each of the benzene rings.
Aspulvinone J-CR (5) was obtained as a pale-yellow solid. Its
molecular formula C27H28O7 was established by HREIMS
[M+Na]+ ion at 487.1733, indicating 14 degrees of unsaturation.
The NMR features of 5 were similar to those of 4 except that the
right-hand benzene ring is trisubstituted, showing a sp2 methine
at C-13 in 5 (dH 7.81, dC 127.8). A COSY cross-peak between
H-13 and H-14 as well as HMBC correlations between H-13
and C-2, C-11 and C-15 confirmed these assignments. These
assignments were reconfirmed by cocrystal structure of 5 with
the FLuc (see below).
Aspulvinone K-CR (6) was isolated as a brown-yellow optically
active oil. The [M+Na]+ ion at m/z 521.1788 in the HREIMS sug-
gested C27H30O9 as the molecular formula, which indicated 18
additional amu, with 1 less unsaturation site than compound 4.
A significant change in the 1H-NMR and 13C-NMR was also
observed in the methine C-19, which shifted from dH 4.63 andChemistry & Biology 18, 1442–145dC 90.7 in 4 to dH 3.64 and dC 79.8 in 6. These modifications
together with the shift of C-9, from dC 161.0 in 4 to dC 157.2 in
6, suggested that there are a hydroxyl and 2,3-dihydroxy-3-
methylbutyl group upon C-9 and C-10, respectively, instead of
the dihydrofuran ring.
Aspulvinone L-CR (7) isolated as a yellow oil gave a [M+Na]+
ion at m/z 505.1838 in the positive ion HREIMS, consistent
with the molecular formula of C27H30O8, and requiring one less
unsaturation site than compound 2. NMR data of compound
7 were similar to those of compound 2 except for C-18 and
C-19. The shifts of C-18 from dH 3.18 and dC 30.0 in 2 to dH
2.96, 2.66 and dC 34.8 in 7, as well as the change in C-19 from
dH 4.60 and dC 89.9 in 2 to dH 3.63 and dC 81.1 in 7, suggests
that in this compound the formation of the dihydrofuran ring
did not occur. Instead, there is the open form where C-10 bears
a 2,3-dihydroxy-3-methylbutyl group, as in compound 6.
Aspulvinone M-CR (8) was isolated as a yellow solid. The
HREIMS gave an [M+Na]+ ion at m/z 503.1682, consistent with
the molecular formula C27H28O8 and the same degrees of unsa-
turation as compound 2. The only difference compared with
compound 2 was the shift of C-24 from dH 1.77 and dC 33.3 in
2 to dH 3.72 and dC 71.0 in 8 due to a secondary hydroxyl group
at C-24.2, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1445
Table 1. Aspulvinone Analogs Tested against Five Luciferase
Variants
Cmp FLuc LmLuc Ultra RLuc VLuc
1 1.4 ± 1.6 3.6 ± 1.1 0.76 ± 0.12 Inactive >57
2 3.6 ± 1.5 2.5 ± 0.5 >57 >57 Inactive
3 1.8 ± 0.9 1.9 ± 0.8 19.0 ± 4.6 >57 >57
4 0.72 ± 0.40 0.50 ± 0.20 4.1 ± 1.8 Inactive 12.0 ± 2.3
5 0.1 ± 0.02 0.1 ± 0.03 4.5 ± 3.8 >57 6.5 ± 3.3
8 1.7 ± 1.6 5.3 ± 5.9 33 ± 2.1 Inactive 18 ± 8
10 Inactive Inactive Inactive >57 >57
11 Inactive Inactive Inactive Inactive >57
12 18.6 ± 8.8 14.8 ± 2.8 31.7 ± 3.0 Inactive Inactive
Data are mean ± SD values, from at least four determinations. All values
are in micromolar (mM). >57, percent (%) inhibition between 20% and
50% at the highest tested concentration of 57 mM; Inactive, percent
(%) inhibition <20% observed at the highest tested concentration.
FLuc, Photinus pyralis luciferase. Related luciferases: LmLuc, Luciola
mingrelica luciferase (82% identical); Ultra, Ultra-Glo luciferase (derived
from Photuris pennsylvanica [68% identical]). Unrelated luciferases:
RLuc, Renilla reniformis luciferase; VLuc, Vibrio fischeri luciferase (Ye
et al., 1997).
Figure 4. NMR and X-ray Analysis of Aspulvinone F (2)
(A) Key 1H-1H COSY and HMBC correlations observed in 2.
(B) X-ray structure of 2. Perspective views showing 50% probability
displacement ellipsoids of an independent aspulvinone F molecule. Na+ is
chelated with four oxygens, two from acetone molecules, and two from
aspulvinone F (2). Carbon atoms are shown in black, oxygen atoms in red,
protons in white, and Na+ in blue.
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with the molecular formula C27H28O7 on the basis of HREIMS
data, [M+H]+ ion at m/z 465.1913. The level of unsaturation is
the same as in compound 2, but the difference in the shifts of
methylene C-18 and methine C-19 indicated the presence of a
dihydropyran with a hydroxyl group at C-19 instead of the
dihydrofuran ring present in 2. Compared with 2, compound 9
showed shifts in the signal H2-18 from dH 3.18 to 3.03, 2.72,
and H-19 signal shifted from dH 4.60 to 3.75. Also, the
13C signals
of C-18 and C-19 shifted from dC 89.9 to 68.7 and from dC 71.1 to
77.2, respectively. COSY correlations between H2-18 and H-19
and HMBC correlations between H2-18 and C-9, C-10, C-11,
C-19, and C-20, as well as between H-19 with C-10, C-18,
C-21, and C-22 were consistent with a hydroxyl group at C-19.
Pulvinones 11–12 (Sugiyama et al., 1979; Rao et al., 2000;
Ojima et al., 1975; Parvatkar et al., 2009) have been isolated
from terrestrial and marine Aspergillus species, whereas 1–3
(Sugiyama et al., 1979; Niu et al., 2008) only from the terrestrial
fungus. Here, we report the isolation of aspulvinones 1–9 from
a marine Aspergillus sp., indicating that although derived from
a completely different environment, this fungus maintains the
capacity for synthesizing this class of compounds.
The aspulvinone family of NPs has a more complex carbon
framework than the related pulvinones due to the incorporation
of two isoprene units. The ortho position to the hydroxyl group
serves as the site for alkylation by a dimethylallyl diphosphate
mediated by a presumed prenyltransferase. Based on isolation
of aspulvinones K-CR and L-CR (compounds 6 and 7), we
surmise that prenylation is followed by epoxidation or dihydrox-
ylation of the double bond with subsequent cyclization, resulting1446 Chemistry & Biology 18, 1442–1452, November 23, 2011 ª2011in the five- or six-membered ring heterocycles. Whether this
represents a common biosynthetic theme that includes pyran
ring formation in the notoamide/stephacidin/paraherquamide
class of fungal-derived alkaloid NPs remains to be explored in
detail (Ding et al., 2010).
Specificity of Aspulvinone Activity
The aspulvinones demonstrated a wide range of activity across
five luciferase species and variants (Table 1). Two of these lucif-
erases (LmLuc and Ultra-Glo) were related to the commonly
utilized luciferase derived from Photinus pyralis (FLuc), and two
were unrelated luciferases that accommodate different sub-
strates and enzymatic mechanisms to produce bioluminescence
(RLuc and VLuc). Analogs of the NP displayed binding affinity for
the related luciferases FLuc, LmLuc, and the thermostable
(Ultra-Glo; Promega) FLucs in the submicromolar range,
whereas potencies decreased to undetectable for the two
species of luciferases that were genetically unrelated to FLuc.
X-ray Cocrystal of Aspulvinone J-CR Bound to FLuc
To further characterize the physical interaction of the aspulvi-
none series with FLuc, apo crystals of the Photinus pyralis lucif-
erase protein were soaked in the presence of aspulvinone J-CR
(5), one of the more potent aspulvinone congeners (Table 1).
Following structural determination by molecular replacement
and subsequent refinement to a resolution of 1.7 A˚, the resulting
electron density maps were examined for ligand binding. Aspul-
vinone J-CR (5) was clearly bound as prominent difference
electron density (Fo-Fc), greater than 3s was observed, which
was consistent with this compound (Figure 5B).
Aspulvinone J-CR (5) fully occupies the D-luciferin binding
site with the isopropyl alcohol at one terminus of the structure
positioning deeply into the D-luciferin binding pocket and the
other isopropyl alcohol extending into the ATP-binding site (Fig-
ure 5A). The aspulvinone molecule adopts a mostly planarElsevier Ltd All rights reserved
Figure 5. Structure of FLuc containing bound aspulvinone J-CR (5)
(A) View of 5 (blue and red cylinders) in the active site of luciferase (gray
ribbons). The ATP and luciferin-binding regions are colored magenta and
green, respectively.
(B) Two views of the Fo-Fc electron density map for 5 contoured at 3 ss.
(C) Hydrogen bonding between 5 (gray/red) and luciferase (cyan). Water
molecules are drawn as red spheres. Direct contacts between luciferase and 5
are shown as dashed lines, and water-mediated interactions are indicated by
the solid lines. Crystallographic data for 5 can be found in Table S2.
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of the benzofuran ring that is positioned in the D-luciferin binding
region is angled 18.9 relative to the mean plane defined by the
hydroxyl-butyrolactone core (Figure 5B). The benzofuran ring inChemistry & Biology 18, 1442–145the ATP-binding region is only 5.8 relative to the hydroxyl-butyr-
olactone mean plane. The isopropyl termini are oriented on the
same side of the three-ring system. In general the driving force
of aspulvinone binding to luciferase is highly enriched by
hydrogen bond interactions (Figure 5C). Two oxygen atoms of
the hydroxyl-butyrolactone core are able to form hydrogen
bonds to the backbone—NH of Gly316 and the hydroxyl group
of Ser347, with the optimal H-bonding distance of 2.73 and
2.85 A˚, respectively. Notably, the isopropyl alcohol on both
ends of the aspulvinone J-CR (5) structure could form tight
binding with the surrounding residues through a hydrogen
bond matrix. The one fitting deeply into the D-luciferin binding
pocket forms a direct hydrogen bond to Arg218 and also a few
water-mediated hydrogen bonds to Arg218, Ala222, Phe227,
and Asn229 through two structural water molecules. In contrast
the other isopropyl alcohol extending into the AMP-binding site
is involved in hydrogen bonding with His245 and the backbone
carbonyl oxygen of Gly316. Additionally, the oxygen of the dihy-
drobenzofuran ring could further help the molecule lock on the
correct binding mode through the hydrogen bond interaction
to Thr343.
Based on the cocrystal structure of FLuc with aspulvinone
J-CR (5), we further examined aspulvinone F (2), which is
30-fold less potent than 5 as a FLuc inhibitor (Table 1). The
docking model of 2 indicated that it could adopt the same
binding orientation and maintain nearly all key interactions as
5. However, the isopropyl alcohol extending into the AMP-
binding site was missing in 2. Because this isopropyl alcohol
forms hydrogen bonds with His245 and the backbone carbonyl
oxygen of Gly316 in 5, the absence of such a moiety in 2 could
explain this significant potency shift (Figure S32).
In a previous study we elucidated inhibitor-based protein
stabilization as the mechanism by which the small molecule
PTC124 increases the activity of a FLuc reporter protein used
in an assay designed to discover nonsense codon-suppressor
compounds (Auld et al., 2008a, 2009a). We found that PTC124
stabilized the half-life of the enzyme by reacting at the FLuc
active site with ATP to form a multi-substrate adduct inhibitor
(MAI), which we determined from crystallographic studies (Auld
et al., 2010; Thorne et al., 2010b). This potent inhibitor can be
displaced from the enzyme through the use of typical luciferase
detection reagents that contain high concentrations of
substrates including CoASH, which presumably thiolytically
cleaves the MAI (Auld et al., 2010), thus allowing detection of
FLuc enzyme activity in the assay. The PTC124-AMP adduct
effectively fills the active site of FLuc. Alignment of the aspulvi-
none cocrystal structure and the structure of PTC124-AMP
adduct in the luciferase active site revealed a similar binding
orientation in the D-luciferin pocket (Figure 6). The hydroxyl-bu-
tyrolactone core of aspulvinone occupies a similar position to the
oxadiazole of PTC124. However, it was found that the central
ring system of aspulvinone J-CR forms an angle of 50.8
between the mean planes defined by the butyrolactone ring
(five membered) and the aryl ring of Phe247. This is too large
for a p-p (face-to-face, quadrupole-quadrupole) interaction or
the aromatic stacking observed in the PTC124-AMP-FLuc struc-
ture, and more closely approximates a herringbone (edge-to-
face, dipole-quadrupole) interaction (Burley and Petsko, 1985,
1988). The planar nature of both ligands makes the molecules2, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1447
Figure 6. Superposition of Aspulvinone J-CR (5) and PTC124-AMP
Adduct within FLuc-Binding Pocket
Protein is shown in ribbon representation, and the binding pocket is depicted
by molecular surface, 5 is shown in green, and PTC124-AMP is shown in cyan.
Phe247 is shown in gray. This figure was prepared with the program VIDA
(OpenEye Scientific Software).
Chemistry & Biology
qHTS Evaluation of Natural Product Extractswell accommodated in the unusually long and linear binding
pocket of D-luciferin.
DISCUSSION
Selection of initial NPEs for bioassay-guided fractionation was
considered carefully given theconsiderable effort in dereplication
required for each follow-up. Our primary consideration was an
apparent pharmacological response, as indicatedbyhigh-quality
CRCs from one or more of the three solvent extracts. Data of this
character were significantly more discriminating than activity
based on a threshold inhibition (e.g., compare analysis of percent
[%] activity versus high-quality curve class activity in Figure 1A),
where even a low false-positive rate can lead to unacceptable
confirmation rates. In addition, given the rare and unique nature
of the NPE samples, we employed the qHTS approach to
measure the activity in as comprehensive a manner as possible.
Comparison of assays using a common detection technology al-
lowed us to flag extracts that interfered with the detection output
and also enabled the identification of the specific FLuc inhibitors
shown in this study. However, in general the diversity of detection
modalities, assay formats, and conditions employed across the
sample of MLPCN assays surveyed here limited our ability to
make optimal use of qHTS data to ascertain whether a CRC
was the result of a pharmacologically mediated event or resulted
from compound-mediated interference in the assay format or
detection modality (Inglese et al., 2006; Thorne et al., 2010b).
Based on these findings, it is evident that another criterion
for follow-up should be whether an NPE is either independently
observed in several cross-validating or orthogonal assay formats
having a common target, or is differentially active within a series
of targets tested in a common assay platform. Coupled with
a qHTS approach, assay panels that provide such a reinforcing
or contrasting result should further improve the efficiency and
probability of identifying isolable-active compounds. In the
present study this approach led us to three assays in which
high-quality CRCs were observed where the common target
was FLuc. Dereplication of the active extract proceeded in
a straightforward manner, leading to the isolation of several1448 Chemistry & Biology 18, 1442–1452, November 23, 2011 ª2011new aspulvinone congeners. Follow-up studies against a series
of bioluminescent enzymes demonstrated that these molecules
are specific for bioluminescent enzymes related to the wild-type
variety of FLucs. The lower overall activity against Ultra-Glo lucif-
erase is consistent with a previous study that suggested a more
restricted inhibitor profile with this thermostable optimized
luciferase (Auld et al., 2009b).
The molecular basis for the high potency and selectivity of
aspulvinone J-CR (5) toward FLuc is revealed in the X-ray coc-
rystal structure. Here, a flat planar structure that binds largely
to the D-luciferin pocket but also can span into the AMP pocket
is observed. The general structural architecture of the aspulvi-
none core bears some resemblance to the diaryl oxidazole found
in molecules like PTC124, which bind to the luciferin pocket of
FLuc, both using a heteroaromatic five-membered ring to bridge
two substituted phenyl moieties. However, unlike PTC124, 5
does not form an MAI through reaction with ATP. In fact ATP is
not bound to FLuc in the presence of 5, presumably due to
protrusion of the isopropyl alcohol of 5 into space normally occu-
pied by the terminal phosphoryl groups of ATP. Furthermore, the
deep pocket present within FLuc, which is not fully occupied
by either luciferin or PTC124, is exploited by 5 and evident by
the extension of the second isopropyl alcohol on the opposite
end of 5 reaching into this deep pocket (Figure 6). These findings
illustrate the chemical diversity capable of interacting with
this pocket and help to further explain the frequent occurrence
of small molecule modulators of FLuc identified in chemical-
screening libraries.
In future uses of NPE libraries, we are exploring incorporation
of a titration-based screening paradigm across common assay
platforms, e.g., in biochemical target-based screens across
gene families (Veith et al., 2009) or in cell-based assays using
the same detection output (Yuan et al., 2009). Such data would
be augmented when properly designed assay panels are config-
ured that differentiate betweenNPEs bearing a technically based
inhibition pattern versus NPEs that are genuinely active on a
biologically relevant mechanism (e.g., contain orthogonal assay
pairs) (Inglese et al., 2007). The combination of qHTSwith panels
containing both parallel and orthogonally designed assays
should facilitate the identification of NPs selective for the target
or cellular pathway being explored from NPE libraries, in the
same way this strategy is used for synthetic chemical libraries
(Johnson et al., 2009; Xia et al., 2009).
We view this study as a work in progress aimed at defining
an improved process for exploring the vast potential of NPs
held within complex mixtures. Focusing here on the use of
microbial-derived NPs prefractionated to remove the majority
of HTS-interfering components, we have employed the pharma-
cological-resolving power of qHTS to reveal apparent IC50
values from these mixtures. By using a pattern of high-quality
CRCs (curve class 1a), we demonstrated that a reproducible
activity could be targeted from among many ‘‘active’’ NPEs
and reduced to a candidate NPE for follow-up dereplication.
Incorporating the wealth of metadata associated with NPEs
can further enhance the CRC information. Metadata information
includes strain, growth conditions, broth or cellular fraction, and
solvent extraction method, which can all be used to guide the
choice of fractions for follow-up. For this purpose we developed
a browser to help visualize and track the metadata informationElsevier Ltd All rights reserved
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we were able to identify a series of aspulvinones that selectively
inhibited the Photinus pyralis FLuc, showing that the widespread
modulation of FLuc activity observed in synthetic chemical
libraries (Auld et al., 2008b) extends to NPEs as well. By applying
the strategy we have outlined here, we are now in a position to
improve the efficiency of NPE screening in drug discovery
applications across a wide range of human and animal disease
targets.
SIGNIFICANCE
The natural world remains a source of great chemical diver-
sity producing compounds demonstrated to have tremen-
dousmedicinal value. However, their use in discovery efforts
has been decreasing because HTS approaches that may be
sufficient for testing of pure synthetic compounds remain
suboptimal for complex mixtures such as natural product
extracts (NPEs). For example typical extracts may harbor
optically active pigments with relatively low concentrations
of bioactive substances. This interference canprevent effec-
tive testing of crudeNPEs at high concentrations in sensitive
fluorescent or luminescent HTS-based assays. Therefore,
both the preparation of the NPE and enhancements to the
screening paradigm are needed. Increasing efficiency for
assessing the biological activity of secondary metabolites
derived from plants, and macro- and microorganisms will
likely reenergize their use in lead discovery efforts. Here,
a library of prefractionated NPEs leads to rapid identification
of active NP molecules. Quantitative HTS (qHTS) enabled
effective investigation of the extracts because the technique
integrates testing of a concentration series that can accom-
modate relatively high apparent micromolar concentrations
for the detection of low-abundance compounds. NPEs con-
taining relevant bioactive molecules were revealed by
sigmoidal CRCs and readily discriminated from inactive
samples. Inclusion of cross-validation assays for a specific
pathway or target, or a common assay platform for testing
multiple cell lines or targets, improved identification of
target-directed or target-selective NPEs, respectively. Given
the effort required to process active fractions derived from
NPEs, the general approach described here should facilitate
the discovery of NPs employing ongoing advances in assay
development and functional genomics.
EXPERIMENTAL PROCEDURES
Preparation of NPE Libraries and Control Plates
Isolated strains from Costa Rican marine sediments were cultured (100 ml)
in two different media (see below). After cell growth, broth was separated by
centrifugation and agitated by shaking overnight with Amberlite XAD-16, which
was further extracted with CH3OH, acetone, and EtOAc sequentially. The
NPEs were transferred to the NIH Chemical Genomics Center (NCGC) on
dry ice in 384-well plates containing 60 ml of a 15 mg/ml solution in DMSO.
The NCGC reformatted the extracts in the HTS compound management
core using the qHTS dilution paradigm (Yasgar et al., 2008) resulting in an
inter-plate or ‘‘through-plate’’ titration series in 1536-well format in DMSO (Fig-
ure S1B). Briefly, fifty 384-well NPE library plates were titrated using a 1:5 dilu-
tion factor, to generate a seven-point titration series. The resulting three
hundred fifty 384-well plates were compressed to ninety-one 1536-well plates
for screening, with the first 4 columns of each plate reserved for assay-specificChemistry & Biology 18, 1442–145controls. Unique identifiers were auto-generated by registering the sample IDs
and strain origins from an accompanying data file into ActivityBase (ID Busi-
ness Solutions Ltd., Guildford, UK). ActivityBase was also used to track the
sample locations in the bar-coded 384-well plates.
Controls were added from columns 1–4 of a separate 1536-well compound
plate. Depending on the assay, titrations, maximum/minimum and/or neutral
controls are used, for example: columns 1–2, 16-point titrations in duplicate
of test compounds starting at 20 mM in DMSO; column 3, neutral control
(DMSO); and column 4, control inhibitor (20 mM resveratrol).
qHTS and Follow-up Data Analysis
The NPE 1536-well titration archive was tested against assays of the MLPCN
using an automated qHTS process described previously (Inglese et al., 2006;
Michael et al., 2008) and described further in the Supplemental Experimental
Procedures.
Curve Classification Analysis
The curve classification used is the same as the one described elsewhere
(Inglese et al., 2006). Briefly, CRCs are categorized into four classes. Class 1
contains complete CRC having both upper and lower asymptotes and
r2 values >0.9. Class 2 contains incomplete CRCs lacking the high-concentra-
tion asymptote and shows r2 values >0.9. Being supported by a single concen-
tration having activity, class 3 curves are considered low confidence. For
class 3 the minimal acceptable activity is set at 3 SD of the mean activity
calculated as described above. Curves are classified as negative or positive,
depending on whether they exhibit a signal decrease (apparent inhibition) or
increase (apparent activation). Finally, class 4 contains compounds that do
not show any activity that define a CRC and are, therefore, classified as inac-
tive. Active compounds were identified as a range of curve classes from 1
through 3 to select for compounds showing signal decreases.
Luciferase Assays
Vibrio fischeri luciferase (VLuc) was purchased from Sigma-Aldrich (catalog
#L8507), which is a partially purified preparation of VLuc that contains the
necessary NADH/NADPH-dependent FMN reductases. Luciferase from
Luciola mingrelica (LmLuc) was purchased from Sigma-Aldrich (catalog
#L4899). Purified wild-type luciferase from Photinus pyralis (FLuc) was ob-
tained from Sigma-Aldrich (catalog #L9506), and purified Ultra-Glo luciferase
was obtained from Promega (Auld et al., 2009b). Renilla reniformis luciferase
(RLuc) was purchased from Nanolight.
The 1536-well RLuc and FLuc assays were performed as previously
described (Auld et al., 2008b, 2009a) using either 5mM coelenterazine or
10 mM D-luciferin and ATP, respectively. The assay for LmLuc used the
same protocol as FLuc with a final concentration of 5 nM LmLuc enzyme.
The assay for Ultra-Glo also used 10 mM D-luciferin and ATP and was per-
formed as described (Auld et al., 2009b). The assay for the FMN-dependent
luciferase VLuc followed the procedure described in Lavi et al. (1981) but
used a miniaturized assay volume of 4 ml in 1536-well plates. For the assay,
2 ml of substrate buffer (0.1 M sodium phosphate [pH 7.0], 0.005% decanal,
0.1% BSA, 0.1 mM NADH, and 2 mM FMN) was dispensed into Kalypsys
white medium binding 1536-well plates. Compounds were then added using
a Kalypsys pin tool. The assay was started by adding enzyme buffer (0.1 M
sodium phosphate [pH 7.0], 0.2 mM VLuc), and the luminescent signal was
read immediately on a PerkinElmer ViewLux (180 s exposure, 63 binning).
Fungal Isolation, Identification, and Cultivation
The fungus Aspergillus sp. (strain 05545) was isolated from a marine sponge
collected in 2005 in La Cruz, Costa Rica, by J. Cortez (authorization accession
permit R-CM-08-2006-OT for samples donated by CIMAR to INBio, collection
permit 106-2005-SINAC). The isolated fungus was preserved with 20% glyc-
erol at 80C. It was cultured in ISP2 media (10 g of malt extract, 4 g of yeast
extract, 4 g of dextrose, and 30 g of NaCl/l of distilled water) at 28Con a rotary
shaker at 200 rpm in five replicates of 2.5 l Fernbach flasks, each containing 1 l
of culture media.
Extraction and Isolation
After 8 days of culture, Aspergillus sp. (strain 05545) fungus cells were har-
vested by centrifugation at 3000 3 g, sonicated, and extracted with MeOH.2, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1449
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shaking overnight, the resin was collected and washed with 1 l of DI water
before it was sequentially extractedwith methanol, acetone, and ethyl acetate.
The resulting extracts were filtered and concentrated to obtain 1.82,
0.87, and 0.26 g of crude extract, respectively. The MeOH extract was sub-
jected to successive chromatography procedures. First, a medium-pressure
reversed-phase LOBAR B (Ø = 25 3 310 mm) LiChroprep column was used,
eluted with MeOH-H2O (7:3) to yield three active fractions: b, c, and d. Frac-
tions b (539 mg), c (510 mg), and d (364 mg) were further subjected to HPLC
purification on a XBridge Prep C18 column (Ø = 10 3 250 mm) with CH3CN-
H2O gradient. The subfractions were further purified on the same column using
phase MeOH-H2O gradient as the mobile phase to give: aspulvinone E
(1, 3.2 mg); aspulvinone F (2, 40 mg); aspulvinone H (3, 6 mg); aspulvinone
I-CR (4, 13 mg); aspulvinone J-CR (5, 4.2 mg); aspulvinone K-CR (6, 7.4 mg);
aspulvinone L-CR (7, 1.8 mg); aspulvinone M-CR (8, 2 mg); aspulvinone
N-CR (9, 5 mg); butyrolactone I (10, 1.6 mg); butyrolactone III (11, 6.6 mg);
and benzofuran (12, 1.8 mg).
General Experimental Procedures for NP Structure Elucidation
Optical rotations were measured on an AUTOPOL III Polarimeter. IR spectra
were recorded with a PerkinElmer BX FT-IR infrared spectrometer using
NaCl plates. Mass spectra were carried out with a Micromass AutoSpec
Ultima Magnetica mass spectrometer. 1H, 13C, and 2D NMR spectra were
recorded in CD3OD on a Varian INOVA 600 MHz NMR spectrometer at
600 MHz for 1H and 150 MHz for 13C, using TMS as an internal standard.
Medium-pressure chromatography was performed using prepacked columns,
including LOBARGRO¨BE B (Ø 253 310mm) LiChroprep RP-18 fromMERCK.
HPLC separations were performed on a Beckman Coulter system (Fullerton,
CA) equipped with a diode-array detector, using a XBridge Prep C18 column
(Ø = 10 3 250 mm). TLC was performed using TLC silica gel 60 F254
from EMD, and plates were visualized by spraying with PMA and heating.
Specific characterization and spectral data for Aspulvinone F (2), Aspulvinone
I-CR (4), Aspulvinone J-CR (5), Aspulvinone K-CR (6), Aspulvinone L-CR (7),
Aspulvinone M-CR (8), and Aspulvinone N-CR (9) are provided in Supple-
mental Experimental Procedures.
Crystallographic Data of Aspulvinone F-CR (2)
Yellow, C132H156Na4O36, monoclinic, space group P21, a = 21.470(6) A˚,
b = 10.861(3) A˚, c = 27.520(7) A˚, b = 93.705(4), V = 6404(3) A˚3, Z = 2, crystal
size 0.32 3 0.28 3 0.08 mm3. The intensities of the reflections were collected
by means of a Bruker APEX II CCD diffractometer (MoKa radiation, l =
0.71073 A˚), and equipped with an Oxford Cryosystems nitrogen flow appa-
ratus. The collectionmethod involved 0.5 scans inu at 26 in 2q. Data integra-
tion down to 0.82 A˚ resolution was carried out using a Bruker SAINT V7.46 A
diffractometer (Madison, WI) with reflection spot size optimization. Absorption
corrections were made with the Bruker program TWINABS (Madison, WI).
The structure was solved by the direct methods procedure and refined by
least-squaresmethods again F2 using SHELXS-97 and SHELXL-97 (Sheldrick,
2008). Nonhydrogen atoms were refined anisotropically, and hydrogen atoms
were allowed to ride on the respective atoms. The Ortep plots were produced
with SHELXL-97 program, and the other drawings were produced with
Accelrys DS Visualizer 2.0 (San Diego, CA).
Cocrystallization and Data Collection for FLuc-Aspulvinone J-CR
Luciferase from Photinus pyralis was purchased from Sigma-Aldrich (catalog
#L9506, lot #017K74201), and concentrated to 10.2 mg/ml in 200 mM
(NH4)2SO4, 1 mM EDTA, 1 mM DTT, 10% glycerol, 25% ethylene glycol, and
25 mM Tris [pH 7.8]) as previously described (Conti et al., 1996). Apo crystals
were obtained at 4C in CombiClover, Jr. (Emerald BioSystems) sitting drop
plates using equal volumes of protein and crystallization solution (25% (v/v),
PEG 400, 20% (v/v) PEG 3350, 0.1 M MgCl2, 0.1 M Tris [pH 8.5], Precipitant
Synergy #41, Emerald BioSystems) equilibrated against 100 ml of the latter.
Apo crystals were soaked for 2.5 hr in the presence of 10 mM NCGC183923
(Aspulvinone J-CR (5)) and 10 mM NCGC183923 (Aspulvinone J-CR (5))/
2.5 mM ATP dissolved in crystallization solution. Diffraction data were
collected at 100 K at the Advanced Photon Source (APS) IMCA-CAT beamline
17-ID using a Dectris Pilatus 6 M pixel array detector.1450 Chemistry & Biology 18, 1442–1452, November 23, 2011 ª2011Structure Solution and Refinement
Diffraction data were integrated and scaled with XDS (Kabsch, 1988) and
Scala (Evans, 2006), respectively. The protein-only coordinates from a previ-
ously determined luciferase structure (using PDB: 3IES) were used for initial
refinement against the processed diffraction data. Refinement and model
building were carried out with PHENIX (Adams et al., 2010) and Coot (Emsley
and Cowtan, 2004), respectively. Disordered side-chain residues were trun-
cated to the point to which electron density could be observed. Structure
validation was conducted with MolProbity (Lovell et al., 2003), and figures
were prepared with CCP4mg (Potterton et al., 2004). Following initial refine-
ment, prominent electron density (Fo-Fc) consistent with NCGC183923
was observed in the active site for the inhibitor and inhibitor/ATP-soaked
crystals. However, no electron density consistent with ATP was observed
for the latter sample. Final structure refinement was conducted using the
diffraction data collected for the NCGC183923/ATP-soaked crystal because
it diffracted to the highest resolution. Crystallographic data are provided in
Table S2.NPE Informatics Browser
Our current primary screening data visualization platform is a two-stage solu-
tion implemented in LabVIEW (Austin, TX): a parser that collates the qHTS data
by microbial strain variant, and a browser that displays the collated data as
a global overview of assays tested against the NPE collection (see Supple-
mental Experimental Procedures).ACCESSION NUMBERS
Coordinates and structure factors of the 1.7 A˚ resolution structure of a firefly
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